Applied DNA Sciences, Inc.
APDN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,946 | $44,150 | $4,822,386 | $8,646,780 |
| - Cash | $4,728 | $6,823 | $9,294 | $6,431 |
| + Debt | $334 | $472 | $607 | $739 |
| Enterprise Value | -$1,447 | $37,799 | $4,813,699 | $8,641,088 |
| Revenue | $304 | $983 | $1,197 | $813 |
| % Growth | -69% | -17.8% | 47.2% | – |
| Gross Profit | $5 | $371 | $684 | $245 |
| % Margin | 1.7% | 37.7% | 57.2% | 30.1% |
| EBITDA | -$3,616 | -$3,217 | -$2,905 | -$3,194 |
| % Margin | -1,187.8% | -327.2% | -242.8% | -392.8% |
| Net Income | -$3,945 | -$27,224 | -$2,639 | -$3,297 |
| % Margin | -1,296.1% | -2,768.4% | -220.6% | -405.5% |
| EPS Diluted | -34 | -15.35 | -0.56 | -0.19 |
| % Growth | -121.5% | -2,641.1% | -194.7% | – |
| Operating Cash Flow | -$2,816 | -$3,185 | -$3,326 | -$3,249 |
| Capital Expenditures | -$11 | -$185 | -$117 | -$371 |
| Free Cash Flow | -$2,827 | -$3,370 | -$3,443 | -$3,620 |